Market Place
Sourcing Support
Dupixent sBLA Accepted for FDA in Chronic Spontaneous Urticaria
15 Nov 2024 //
GLOBENEWSWIRE
Sarclisa Recommended for EU Approval for Multiple Myeloma
14 Nov 2024 //
GLOBENEWSWIRE
Sanofi will deploy new AI tool in late-stage MS trials
14 Nov 2024 //
FIERCE BIOTECH
Healx Partners with Sanofi to Explore Rare Disease AI Drug Discovery
13 Nov 2024 //
BUSINESSWIRE
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
12 Nov 2024 //
FIERCE PHARMA
Novo, Lilly lost value in Q3 while BMS, Gilead and Sanofi surged
11 Nov 2024 //
FIERCE PHARMA
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
11 Nov 2024 //
FIERCE PHARMA
MediciNova Faces Monetary Damages from Sanofi-Novartis Patent
11 Nov 2024 //
GLOBENEWSWIRE
Accumulus Platform Supports Sanofi’s Global Regulatory Submissions
07 Nov 2024 //
GLOBENEWSWIRE
Sanofi`s BTK inhibitor raises platelet 23% of ITP patients
07 Nov 2024 //
FIERCE BIOTECH
Dupixent Approved in EU for Children with Eosinophilic Esophagitis
06 Nov 2024 //
GLOBENEWSWIRE
Sanofi`s Biologic Soliqua Receives Suppl Approval in US
01 Nov 2024 //
FDA
Regeneron Reports Q3 2024 Financial and Operating Results
31 Oct 2024 //
GLOBENEWSWIRE
Kymera Therapeutics Reports Q3 2024 Financial Results
31 Oct 2024 //
GLOBENEWSWIRE
Resalis Therapeutics Gains Strategic Equity Investment from Sanofi
28 Oct 2024 //
BUSINESSWIRE
Sanofi Beats Q3 Forecasts Fueled by 381% Growth in Beyfortus Sales
26 Oct 2024 //
BIOSPACE
Sanofi isn`t sweating a potential RSV showdown with Merck
26 Oct 2024 //
FIERCE PHARMA
Sanofi`s Biologic Sarclisa Receives Suppl Approval in US
25 Oct 2024 //
FDA
Sanofi Q3: 15.7% Sales Growth from Vaccine Sales Boost
25 Oct 2024 //
GLOBENEWSWIRE
Sanofi Q3 earnings beat market view, boosted by vaccine sales
24 Oct 2024 //
REUTERS
Dupixent Presents Late-Breaking Phase 3 Data At ACAAI
24 Oct 2024 //
GLOBENEWSWIRE
Sanofi enters exclusive talks with CD&R for Opella sale
21 Oct 2024 //
REUTERS
Sanofi `surprised` by PAI Partners` raised bid for Opella unit
17 Oct 2024 //
REUTERS
Sanofi and Orano join to develop Next-Gen radioligand medicines
17 Oct 2024 //
GLOBENEWSWIRE
Sanofi Commits $18 Million To Increase Diversity In Clinical Studies
16 Oct 2024 //
PR NEWSWIRE
FLUBLOK® Vaccine Label Updated With Safety Study In Pregnant
16 Oct 2024 //
PR NEWSWIRE
Sanofi commits $18M to 3 HBCUs to boost clinical trial diversity
16 Oct 2024 //
FIERCE BIOTECH
Exscientia Achieves Milestones In Sanofi Collaboration Programs
16 Oct 2024 //
BUSINESSWIRE
Sanofi Updates Information Total Voting Rights And Shares
15 Oct 2024 //
GLOBENEWSWIRE
EUROAPI closes the financing of its FOCUS-27 plan
15 Oct 2024 //
PRESS RELEASE
Regeneron and Sanofi’s Dupixent to Dominate COPD Biologics Market
15 Oct 2024 //
BIOSPACE
Sanofi in talks to sell 50% stake in consumer health business to CD&R
12 Oct 2024 //
REUTERS
Sanofi flunks MS study, dealing another blow to Denali pact
11 Oct 2024 //
FIERCE BIOTECH
Sanofi’s Dulcolax crowns ‘Pooping Princesses’ to fight stigma
11 Oct 2024 //
FIERCE PHARMA
Sanofi in discussions to sell a controlling stake in Opella
11 Oct 2024 //
GLOBENEWSWIRE
Denali-Sanofi scraps mid-stage study for multiple sclerosis drug
11 Oct 2024 //
REUTERS
breast cancer pill could enter $12 bln market if trials succeed
09 Oct 2024 //
REUTERS
Sanofi unveils new educational website on MS progression
09 Oct 2024 //
FIERCE PHARMA
New Beyfortus Data Featured At IDWeek On RSV In Infants
09 Oct 2024 //
GLOBENEWSWIRE
New Beyfortus Data Shows Effectiveness Against RSV At IDWeek
08 Oct 2024 //
GLOBENEWSWIRE
Thermo Fisher`s Infant making RSV Drug Plant Breached FDA Rules
05 Oct 2024 //
REUTERS
GSK, Sanofi, CSL nab BARDA funding for bird flu shots
05 Oct 2024 //
FIERCE PHARMA
Recordati buys rights to rare immune drug from Sanofi for $825 mln
05 Oct 2024 //
REUTERS
Sanofi and Regeneron’s Dupixent Snags First Biologic Approval in COPD
28 Sep 2024 //
BIOSPACE
Dupixent Approved In U.S. As First Biologic For COPD
27 Sep 2024 //
GLOBENEWSWIRE
J&J counters Sanofi`s Sarclisa nod with Darzalex data drop
27 Sep 2024 //
FIERCE PHARMA
Press Release: Availability of the Q3 2024 Aide mémoire
26 Sep 2024 //
GLOBENEWSWIRE
Sanofi: Poland`s EU Presidency Boosts Pharma Competitiveness
25 Sep 2024 //
PR NEWSWIRE
Sanofi gets two bids valuing, consumer health unit $17 billion "
25 Sep 2024 //
REUTERS
Sanofi plucks new CSO from in-stealth biotech
24 Sep 2024 //
FIERCE BIOTECH
Sanofi CEO believes company poised for growth from new drugs
24 Sep 2024 //
REUTERS
Sanofi makes $27M equity investment in Ventyx
23 Sep 2024 //
FIERCE BIOTECH
Sanofi wins US approval for multiple myeloma drug
23 Sep 2024 //
REUTERS
Sanofi `s Biologic Sarclisa (Isatuximad) Receives Suppl Approval in US
20 Sep 2024 //
FDA
Panacea Biotec and Sanofi reached settlement agreement for Shan6
17 Sep 2024 //
INDIANPHARMAPOST
Sanofi: Voting Rights And Shares Info - August 2024
16 Sep 2024 //
GLOBENEWSWIRE
Sanofi, AstraZeneca win US approval for RSV therapy manufacturing line
16 Sep 2024 //
REUTERS
Sanofi Begins US Shipments Of RSV Drug BEYFORTUS
16 Sep 2024 //
PR NEWSWIRE
Sanofi Consumer Healthcare India listed on BSE and NSE
14 Sep 2024 //
EXPRESSPHARMA
Dupixent Approved For Adolescents With Chronic Rhinosinusitis With Polyps
13 Sep 2024 //
GLOBENEWSWIRE
